Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Observation studies suggest that coffee consumption may lower the risk and delay the age-at-onset (AAO) of Parkinson's disease (PD). The aim of this study was to explore the causal relationship and genetic association between coffee consumption and the AAO, risk, and progression of PD. Using Mendelian randomization, we identified a significant association between coffee consumption and delayed PD AAO (IVW: OR, 1.91; 95% CI 1.53-2.38; p = 8.072e-09), but no causal association or genetic correlation with PD risk or progression. Our findings suggest a potential causal effect of higher coffee consumption on PD AAO, with no evidence of an association with PD risk or progression.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.